USPTO serial 99705370
PEDESTAL HEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SNABB, SANDRA MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with PEDESTAL HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Indianapolis, IN, US
Indianapolis, IN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amy Wright
Amy Wright Taft Stettinius & Hollister LLPOne Indiana Square, Suite 3500Indianapolis, IN 46402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for clinical research, healthcare analytics, and pharmaceutical development; Downloadable computer software for clinical research data management, healthcare data analytics, pharmaceutical research; Downloadable computer software using artificial intelligence (AI) for analyzing medical and life sciences data | ACTIVE | — |
| 035 | Data processing services in the field of clinical research, healthcare analytics, and pharmaceutical development; Data processing services in the field of medical research; Data processing services; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable cloud-based software for clinical research, healthcare analytics, and pharmaceutical development; Software as a service (SAAS) services featuring software for clinical research, healthcare analytics, and pharmaceutical development; Software as a service (SAAS) services featuring software for real-world data (RWD) analysis and real-world evidence (RWE) generation; Platform as a service (PAAS) featuring computer software platforms for clinical research, healthcare analytics, and pharmaceutical development; Platform as a service (PAAS) featuring computer software platforms for clinical trial design and optimization; Providing temporary use of non-downloadable cloud-based software for clinical research data aggregation, harmonization, management, analytics, and visualization; Design and development of computer software for pharmaceutical research and healthcare analytics; Application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software and web sites of others in the fields of clinical research collaboration; Hosting an on-line community web site featuring clinical research collaboration; Computer services, namely, hosting and maintaining an on-line web site for others for clinical research collaboration; Computer services, namely, hosting an interactive web site that allows clinical research collaboration; Hosting on-line web facilities for others for clinical research collaboration; Scientific research and development; Computer programming services for data processing; Software engineering services for data processing; Consulting services for others in the field of design, planning, and implementation project management of clinical trials for others; Scientific research in the nature of conducting clinical trials for others; Medical and scientific research in the field of pharmaceuticals; Compiling data for research purposes in the field of medical science and medical consultancy; Providing information about medical research in the field of drug development; Medical research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 22, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 16, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 27, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 27, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 16, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 16, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2026 | NWAP | NEW APPLICATION ENTERED | — |